Innoviva (INVA) Current Taxes (2022 - 2025)

Innoviva (INVA) posted Current Taxes of $274000.0 for Q4 2025, down 82.23% on a QoQ basis from $1.5 million in Q1 2025.

Innoviva (INVA) Current Taxes (2022 - 2025) Analysis & Trends

Innoviva's Current Taxes history runs 4 years deep, the most recent figure standing at $274000.0 for Q4 2025.

Quarterly Current Taxes changed N/A year-over-year to $274000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $274000.0 (changed N/A YoY) and the FY2025 annual result came in at $274000.0, changed N/A from the prior year.
Current Taxes was $274000.0 for Q4 2025 at Innoviva, down from $1.5 million in the prior quarter.
Across five years, Current Taxes topped out at $33.8 million in Q3 2022 and bottomed at $154000.0 in Q4 2022.
A 4-year average of $4.9 million and a median of $214000.0 in 2022 frame the typical range for Current Taxes.
Annual changes were most pronounced in 2023 — Current Taxes tumbled 99.54% — and 2024, when it soared 1603.25%.
Innoviva's Current Taxes stood at $154000.0 in 2022, then changed by 0.0% to $154000.0 in 2023, then surged by 1603.25% to $2.6 million in 2024, then tumbled by 89.55% to $274000.0 in 2025.
Business Quant data shows INVA's Current Taxes at $274000.0 in Q4 2025, $1.5 million in Q1 2025, and $2.6 million in Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	63.52 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	49.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Innoviva	1.57 Bn	969.11 Mn	75.83 Mn	-

Download Data